↓ Skip to main content

Anti-PD-1/PD-L1 for nasopharyngeal carcinoma: a comprehensive analysis of registered trials on ClinicalTrials.gov

Overview of attention for article published in Frontiers in Pharmacology, November 2023
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
1 Dimensions
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Anti-PD-1/PD-L1 for nasopharyngeal carcinoma: a comprehensive analysis of registered trials on ClinicalTrials.gov
Published in
Frontiers in Pharmacology, November 2023
DOI 10.3389/fphar.2023.1212813
Pubmed ID
Authors

Zelei Dai, Nian Li, Jun Wang, Chenfeng Tan, Yonggang Zhang, Lei Liu

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 November 2023.
All research outputs
#20,263,067
of 24,914,266 outputs
Outputs from Frontiers in Pharmacology
#9,692
of 19,046 outputs
Outputs of similar age
#162,621
of 239,482 outputs
Outputs of similar age from Frontiers in Pharmacology
#111
of 480 outputs
Altmetric has tracked 24,914,266 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 19,046 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 239,482 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 480 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.